Micromechanical devices for control of cell-cell interaction, and methods of use thereof

Patent metadata

Field	Value
Publication number	US-9611453-B2
Application number	US-44999408-A
Country	US
Kind code	B2
Filing date	Mar 10, 2008
Priority date	Feb 8, 2007
Publication date	Apr 4, 2017
Grant date	Apr 4, 2017

Abstract

The development and function of living tissues depends largely on interactions between cells that can vary in both time and space; however, temporal control of cell-cell interaction is experimentally challenging. By employing a micromachined silicon substrate with moving parts, herein is disclosed the dynamic regulation of cell-cell interactions via direct manipulation of adherent cells with micron-scale precision. The inventive devices and methods allow mechanical control of both tissue composition and spatial organization. The inventive device and methods enable the investigation of dynamic cell-cell interaction in a multitude of applications, such as intercellular communication, spanning embryogenesis, homeostasis, and pathogenic processes.

First claim

We claim:

1. A method for dynamically controlling a co-culture of cells, comprising the steps of:
(a) culturing at least one cell of a first type on a first micromechanical substrate, thereby providing a first population of cells;
(b) culturing at least one cell of a second type on a second micromechanical substrate, thereby providing a second population of cells;
(c) placing the first micromechanical substrate in contact with the second micromechanical substrate for a first period of time, thereby providing direct cell-cell contact between the first population of cells and the second population of cells; and
(d) placing the first micromechanical substrate at a distance from the second micromechanical substrate for a second period of time, thereby preventing direct cell-cell contact between the first population of cells and the second population of cells while providing exposure to soluble factors produced by the first or second population of cells, wherein the distance is in the range of about 1 μm to about 1,000 μm;
thereby dynamically controlling the co-culture of cells.

2. The method of claim 1 , wherein the at least one cell of a first type is a plurality of cells of a first type; the at least one cell of a second type is a plurality of cells of a second type; the cells of a first type are target cells comprising a receptor; the cells of a second type secrete a soluble signal; and the co-culturing results in exposing cells to cytokines.

3. The method of claim 2 , further comprising the step of determining the effect of a soluble signal exposure on the cells of a first type.

4. The method of claim 2 , wherein the cells of a first type are mammalian cells.

5. The method of claim 2 , wherein the cells of a first type are human cells.

6. The method of claim 2 , wherein the cells of a first type comprise receptors for a member of the VEGF family, VEGF-D, a member of the MIP family, MIP- 1γ, ceruloplasmin, nitric oxide, gases, or growth factors.

7. The method of claim 2 , wherein the cells of a first type comprise DLK, Dlk-1, a cadherin, or T- cadherin.

8. The method of claim 2 , wherein the cells of a second type are mammalian cells.

9. The method of claim 2 , wherein the cells of a second type are human cells.

10. The method of claim 2 , wherein the cells of a second type secrete hematopoietins, interferons, tumor necrosis factors, chemokines, or a combination thereof.

11. The method of claim 2 , wherein the cells of a second type secrete a member of the VEGF family, VEGF-D, a member of the MIP family, MIP-1γ, ceruloplasmin, nitric oxide, gases, or growth factors.

12. The method of claim 1 , wherein the at least one cell of a first type is a plurality of cells of a first type; the at least one cell of a second type is a plurality of cells of a second type; the cells of a first type are target cells comprising a cytokine receptor; the cells of a second type secrete a cytokine; and the co-culturing results in exposing cells to cytokines.

13. The method of claim 12 , further comprising the step of determining the effect of a cytokine exposure on the cells of a first type.

14. The method of claim 12 , wherein the cells of a first type are mammalian cells.

15. The method of claim 12 , wherein the cells of a first type are human cells.

16. The method of claim 12 , wherein the cells of a first type comprise cytokine receptors selected from the group consisting of hematopoietin family receptors, interferon family receptors, tumor necrosis factor family receptors, and chemokine family receptors.

17. The method of claim 12 , wherein the cells of a first type comprise cytokine receptors selected from the group consisting of receptors for IL-1 α, IL-I β, IL-2, IL3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-12, IL-15, GM-CSF, IFN-α, IFN-β, IFN-γ, TNF-α, TNF-β, CD40, Fas, MIP-1 α, MIP-1 β, RANTES, CCR5, and CXCR4.

18. The method of claim 12 , wherein the cells of a second type are mammalian cells.

19. The method of claim 12 , wherein the cells of a second type are human cells.

20. The method of claim 12 , wherein the cells of a second type secrete hematopoietins, interferons, tumor necrosis factors, chemokines, or a combination thereof.

21. The method of claim 12 , wherein the cells of a second type secrete IL-1 α, IL-1 β, IL2, IL-3, IL-4, IL-S, IL-6, IL-7, IL-8, IL-9, IL-12, IL-15, GM-CSF, IFN- α, IFN-β, IFN- γ, TNF-α, TNF- β, CD40, Fas, MIP-1 α, MIP-1β, RANTES, CCR5, or CXCR4.

22. The method of claim 1 , wherein the distance is in the range of about 10 μm to about 200 μm.

23. The method of claim 1 , wherein the distance is in the range of about 50 μm to about 100 μm.

24. The method of claim 1 , wherein the first substrate is fabricated from silicon, polystyrene, quartz, glass, fused silica, SU-8, PDMS, polypropylene, epoxies, polymers, ceramics or metals.

25. The method of claim 1 , wherein the second substrate is fabricated from silicon, polystyrene, quartz, glass, fused silica, SU-8, PDMS, polypropylene, epoxies, polymers, ceramics or metals.

26. The method of claim 1 , wherein the first substrate is partially or completely coated with polystyrene.

27. The method of claim 1 , wherein the second substrate is partially or completely coated with polystyrene.

28. The method of claim 1 , wherein the first substrate is partially or completely coated with collagen.

29. The method of claim 1 , wherein the second substrate is partially or completely coated with collagen.

30. The method of claim 1 , wherein the first substrate is fabricated from an optically transparent material.

31. The method of claim 1 , wherein the first substrate is fabricated from an optically translucent material.

32. The method of claim 1 , wherein the second substrate is fabricated from an optically transparent material.

33. The method of claim 1 , wherein the second substrate is fabricated from an optically translucent material.

34. The method of claim 1 , wherein the at least one cell of a first type is not the same as the at least one cell of the second type.

Assignees

• Bhatia Sangeeta N
• Hui Elliot
• Univ California

Inventors

• Bhatia Sangeeta N
• Hui Elliot

Classifications

• C12M23/04

  Flat or tray type, drawers (C12M23/10, C12M23/12, C12M23/16 take precedence) · CPC title

• C12M35/08 Primary

  Chemical, biochemical or biological means, e.g. plasma jet, co-culture · CPC title

• C12M23/20

  Material Coatings (immunocoatings C12M25/00) · CPC title